SCHEMBL6926546

SCHEMBL6926546

Oc1cccc2c1c1cccc(Cl)c1n2Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.47
PLA2G2A P14555 2/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
ALDH1A1 P00352 4/20 0.47
MAPT P10636 4/20 0.47
KDM4E B2RXH2 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SRC P12931 3/20 0.45
ESR1 P03372 1/20 0.44
P2RX4 Q99571 1/20 0.43
MAPK1 P28482 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.41
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RGS12 O14924 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL7510140 0.91 PLA2G2A (0.41) CYP19A1PLA2G2AMEN1KMT2AALDH1A1
SCHEMBL6924605 0.88 MEN1 (0.43) PLA2G2AMEN1KMT2AALDH1A1MAPT
SCHEMBL6924122 0.84 PLA2G2A (0.46) CYP19A1PLA2G2AMEN1KMT2AALDH1A1
SCHEMBL6927392 0.84 ATM (0.53) CYP19A1PLA2G2AMEN1KMT2AALDH1A1
SCHEMBL6921173 0.83 CYP19A1 (0.65) CYP19A1PLA2G2AMEN1KMT2AALDH1A1
SCHEMBL6924327 0.76 SRC (0.51) CYP19A1PLA2G2AMEN1KMT2AALDH1A1
SCHEMBL6921052 0.75 MEN1 (0.43) PLA2G2AMEN1KMT2AALDH1A1MAPT
Bromide SCHEMBL7510146 0.75 ESR1 (0.38) CYP19A1MEN1KMT2AALDH1A1MAPT
SCHEMBL7723992 0.74 SRC (0.53) CYP19A1PLA2G2AMEN1KMT2AALDH1A1
SCHEMBL6926616 0.73 LMNA (0.44) PLA2G2AMEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1169789-C Aminoalkoxy carbazoles for the treatment of CNS diseases 法玛西雅厄普约翰美国公司 2004-10-06 CN disclosed
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
CN-1372547-A Aminoalkoxy carbazoles for the treatment of CNS diseases UPJOHN CO (US) 2002-10-02 CN disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed